Integration of glycosphingolipid metabolism and cell-fate decisions in cancer and stem cells: review and hypothesis
- PMID: 15514480
- DOI: 10.1023/B:GLYC.0000046274.35732.47
Integration of glycosphingolipid metabolism and cell-fate decisions in cancer and stem cells: review and hypothesis
Abstract
The metabolism of glycosphingolipids is strictly regulated during the mitotic cell cycle. Before the G1-to-S transition, the ceramide and glucosylceramide concentration is elevated. Ceramide induces apoptosis synergistically with the pro-apoptotic protein prostate apoptosis response 4 (PAR-4) that may be asymmetrically inherited during cell division. Only one daughter cell dies shortly after mitosis, a mechanism we suggested to regulate the number of neural stem cells during embryonic development. The progeny cells, however, may protect themselves by converting ceramide to glucosylceramide and other glycosphingolipids. In particular, complex gangliosides have been found to sustain cell survival and differentiation. The cell cycle may thus be a turning point for (glyco)sphingolipid metabolism and explain rapid changes of the sphingolipid composition in cells that undergo mitotic cell-fate decisions. In the proposed model termed "Shiva cycle", progression through the cell cycle, differentiation, or apoptosis may rely on a delicate balance of (glyco)sphingolipid second messengers that modulate the retinoblastoma-dependent G1-to-S transition or caspase-dependent G1-to-apoptosis program. Ceramide-induced cell cycle delay at G0/G1 is either followed by ceramide-induced apoptosis or by conversion of ceramide to glucosylceramide, a proposed key regulatory rheostat that rescues cells from re-entry into a life/death decision at G1-to-S. We propose a mechanistic model for sphingolpid-induced protein scaffolds ("slip") that regulate cell-fate decisions and will discuss the biological consequences and pharmacological potential of manipulating the (glyco)sphingolipid-dependent cell fate program in cancer and stem cells.
Similar articles
-
Regulation of cell death in mitotic neural progenitor cells by asymmetric distribution of prostate apoptosis response 4 (PAR-4) and simultaneous elevation of endogenous ceramide.J Cell Biol. 2003 Aug 4;162(3):469-79. doi: 10.1083/jcb.200212067. Epub 2003 Jul 28. J Cell Biol. 2003. PMID: 12885759 Free PMC article.
-
Diabetes alters sphingolipid metabolism in the retina: a potential mechanism of cell death in diabetic retinopathy.Diabetes. 2006 Dec;55(12):3573-80. doi: 10.2337/db06-0539. Diabetes. 2006. PMID: 17130506 Free PMC article.
-
Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.Cancer Res. 1996 Dec 1;56(23):5309-18. Cancer Res. 1996. PMID: 8968075 Review.
-
Therapeutic potential of _targeting ceramide/glucosylceramide pathway in cancer.Cancer Chemother Pharmacol. 2013 Jan;71(1):13-20. doi: 10.1007/s00280-012-1984-x. Epub 2012 Oct 17. Cancer Chemother Pharmacol. 2013. PMID: 23073611 Review.
-
Cell-permeable ceramide inhibits the growth of B lymphoma Raji cells lacking TNF-alpha-receptors by inducing G0/G1 arrest but not apoptosis: a new model for dissecting cell-cycle arrest and apoptosis.Leukemia. 1996 Dec;10(12):1950-8. Leukemia. 1996. PMID: 8946936
Cited by
-
Identification of functional long non-coding RNAs in gastric cancer by bioinformatics analysis.Int J Exp Pathol. 2020 Jun;101(3-4):96-105. doi: 10.1111/iep.12350. Epub 2020 Jul 1. Int J Exp Pathol. 2020. PMID: 32608553 Free PMC article.
-
Sphingolipids and expression regulation of genes in cancer.Prog Lipid Res. 2011 Jan;50(1):104-14. doi: 10.1016/j.plipres.2010.10.003. Epub 2010 Oct 21. Prog Lipid Res. 2011. PMID: 20970453 Free PMC article. Review.
-
Adamantyl glycosphingolipids provide a new approach to the selective regulation of cellular glycosphingolipid metabolism.J Biol Chem. 2011 Jun 17;286(24):21413-26. doi: 10.1074/jbc.M110.207670. Epub 2011 Apr 25. J Biol Chem. 2011. PMID: 21518770 Free PMC article.
-
It's a lipid's world: bioactive lipid metabolism and signaling in neural stem cell differentiation.Neurochem Res. 2012 Jun;37(6):1208-29. doi: 10.1007/s11064-011-0698-5. Epub 2012 Jan 14. Neurochem Res. 2012. PMID: 22246226 Free PMC article. Review.
-
Polar lipid remodeling and increased sulfatide expression are associated with the glioma therapeutic candidates, wild type p53 elevation and the topoisomerase-1 inhibitor, irinotecan.Glycoconj J. 2010 Jan;27(1):27-38. doi: 10.1007/s10719-009-9249-6. Epub 2009 Jun 26. Glycoconj J. 2010. PMID: 19557511
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical